Flow Contract Site Laboratory Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Flow Contract Site Laboratory's estimated annual revenue is currently $1.9M per year.(i)
  • Flow Contract Site Laboratory's estimated revenue per employee is $155,000

Employee Data

  • Flow Contract Site Laboratory has 12 Employees.(i)
  • Flow Contract Site Laboratory grew their employee count by 0% last year.

Flow Contract Site Laboratory's People

NameTitleEmail/Phone
1
Owner/Laboratory DirectorReveal Email/Phone
2
President, Flow Cytometry SpecialistReveal Email/Phone
3
Research AssociateReveal Email/Phone
4
Study CoordinatorReveal Email/Phone
5
Lead Study CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$5.1M336%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M48-21%$16MN/A
#7
$1.1M70%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M5-17%N/AN/A
Add Company

What Is Flow Contract Site Laboratory?

Flow Contract Site Laboratory, LLC is a specialized contract research organization (CRO) that offers non-GLP and GLP flow cytometry services for research, nonclinical and clinical drug development. Some of our capabilities include up to 8-color antibody panels for immunophenotyping, receptor occupancy, intracellular cytokine and phospho-protein detection, cell cycle arrest and progression, antigen stability and cellular functional assays. We can also perform bead-based assays for excreted cytokine detection and HLA antibodies. We are proficient in processing a multitude of specimen types including whole blood, tissue, frozen PBMCs and tumors for pre-clinical model systems and human clinical trials.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M1250%N/A
#2
$1.3M13-19%$5M
#3
$1.3M157%N/A
#4
$2.4M150%N/A
#5
$1.3M15-17%N/A